Newspaper advertisement of unaudited financial results for the quarter and Nine months ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd has submitted copies of newspaper advertisements of its unaudited financial results for Q3 FY26 (quarter ended December 31, 2025) and the nine-month period ended December 31, 2025. The ads were published in Business Standard (English) on February 16, 2026 and Loksatta (Gujarati) on February 15, 2026, as required under SEBI listing rules. For Q3 FY26, total income from operations rose to Rs. 653.37 lakhs from Rs. 478.09 lakhs in the previous quarter, and the company swung to a net profit of Rs. 6.43 lakhs from a loss of Rs. 66.11 lakhs in Q2 FY26. For the nine-month period, revenue grew to Rs. 2,089.87 lakhs (vs Rs. 1,905.54 lakhs a year ago) and the company reported a net profit of Rs. 47.45 lakhs compared to a loss of Rs. 65.39 lakhs in 9M FY25. EPS for 9M FY26 stood at Rs. 1.09 versus a loss per share of Rs. 1.52 in the year-ago period.
The company has shown a sequential and year-on-year turnaround from losses to profits, with revenue also improving. This is a positive development for shareholders, though absolute profit levels remain small relative to the equity base of Rs. 444.06 lakhs.